Aggressive vs. Conservative Blood Pressure Reduction in Acute Intracerebral Hemorrhage: A Systematic Review and

Gabriel Semione1, Marcio Yuri Ferreira2, Ahmet Gunkan3

  • 1Department of Medicine, University of West Santa Catarina, Joaçaba, Brazil.

Insights

Aggressive blood pressure lowering in intracerebral hemorrhage showed similar functional outcomes and mortality compared to conservative management. However, aggressive lowering was associated with fewer adverse events and potential modest functional benefits.

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Clinical Trials

Background:

  • Intracerebral hemorrhage (ICH) is associated with high mortality and disability.
  • Optimal blood pressure (BP) management following ICH remains uncertain, with ongoing debate between aggressive and conservative lowering strategies.

Purpose of the Study:

  • To compare the efficacy and safety of aggressive versus conservative blood pressure lowering strategies in patients with intracerebral hemorrhage.
  • To evaluate the impact on functional outcomes, mortality, and hematoma growth.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials (RCTs) sourced from PubMed, Web of Science, Embase, and Cochrane up to August 2025.
  • Inclusion of only open-label, blinded-endpoint RCTs.
  • Independent data extraction by two authors, with conflicts resolved by a third.

Main Results:

  • Eight RCTs involving 12,669 patients were analyzed.
  • No significant differences were found between aggressive and conservative BP lowering for functional outcomes (excellent/good recovery) or 90-day mortality.
  • Aggressive BP lowering was associated with a reduction in adverse events (RR, 0.87; 95% CI, 0.76-0.99; p = 0.03).
  • Sensitivity and subgroup analyses suggested potential modest functional benefits with aggressive BP lowering, though not consistently confirmed.

Conclusions:

  • Both aggressive and conservative blood pressure management strategies in ICH result in comparable functional recovery, mortality rates, and hematoma growth.
  • Aggressive BP lowering demonstrates a favorable safety profile with fewer adverse events.
  • Subgroup analyses indicate a potential for modest functional improvements with aggressive BP management.
Abstract